(e) Assuming the accuracy of the representations and warranties of Subscriber set forth in Section 4 of this Subscription Agreement, the Company is not required to obtain any consent, waiver, authorization, order or approval, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization (including the Stock Exchange) or other person in connection with the execution, delivery and performance of this Subscription Agreement (including, without limitation, the issuance of the Subscribed Shares), other than (i) filings required by applicable state securities laws, (ii) filings required by applicable state banking and money transmitter licensing authorities, (iii) the filing of the Registration Statement pursuant to Section 5 below, (iv) filings required by the United States Securities and Exchange Commission (“Commission”), (v) those required by the Stock Exchange, (vi) those required to consummate the Transaction as provided under the Transaction Agreement, (vii) the filing of notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, if applicable, (viii) filings required in connection with the Relisting and the Domestication, and (ix) the failure of which to obtain would not be reasonably likely to have a Company Material Adverse Effect.
(f) As of their respective dates, all reports required to be filed by the Company with the Commission (the “SEC Reports”) complied in all material respects with the requirements of the Securities Act and the Securities Exchange Act of 1934, and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing and fairly present in all material respects the financial position of the Company as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments. The Company timely filed each report, statement, schedule, prospectus, and registration statement that the Company was required to file with the Commission since its inception. There are no material outstanding or unresolved comments in comment letters from the staff of the Commission with respect to any of the SEC Reports.
(g) As of the date hereof, the authorized capital stock of the Company consists of 220,000,000 ordinary shares, par value of $0.0001 per share (“Ordinary Shares”), including 200,000,000 Class A Ordinary Shares, 20,000,000 Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”), and 1,000,000 preference shares, par value of $0.0001 per share (“Preference Shares”). As of immediately prior to the Closing and prior to giving effect to any of the Transactions contemplated by the Transaction Agreement (other than the Domestication), the authorized capital stock of the Company will consist of 1,001,000,000 shares of capital stock, consisting of 750,000,000 shares of Class A common stock, 250,000,000 shares of Class V common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. As of the date hereof: (i) 20,737,202 Class A Ordinary Shares are issued and outstanding, 5,184,300 Class B Ordinary Shares are issued and outstanding and no Preference Shares are issued and outstanding; (ii) 16,516,041 warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share (“Warrants”), are issued and outstanding, including 6,147,440 private placement warrants; and (iii) no Class A Ordinary Shares was subject to issuance upon exercise of outstanding options. No Warrants are exercisable on or prior to the Closing.
(h) All issued and outstanding Ordinary Shares have been duly authorized and are validly issued, fully paid and non-assessable and are not subject to preemptive rights. As of the date hereof, except as set forth above and pursuant to (i) the Other Subscription Agreements, or (ii) the Transaction Agreement (including the exhibits and schedules thereto), there are no outstanding options, warrants or other rights to subscribe for, purchase or acquire from the Company any
5